AN2 Therapeutics, Inc. (ANTX)

3.61 +0.47 (+14.97%) USD  |  NASDAQ  |  Apr 17, 16:00
3.62 +0.01 (+0.28%) After-Hours: 20:00
More

AN2 Therapeutics Return on Net Operating Assets (Annual)

Return on Net Operating Assets (Annual) Chart

View Return on Net Operating Assets (Annual) for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets (Annual) Range, Past 5 Years

View Return on Net Operating Assets (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets (Annual) Benchmarks

View Return on Net Operating Assets (Annual) Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade